Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-11-8
|
pubmed:abstractText |
The hypothalamic pituitary axis was studied in patients with an abnormal pattern of gonadotropin release during chronic treatment with LH-RH agonist. Two patients had PCOD and the third demonstrated the early luteinization phenomenon. Following a well-defined gonadotropin rise with initiation of LH-RH treatment, no further response was noted. Stabilization of the LH:FSH ratio in PCOD patients was noted after 4 weeks of treatment. Administration of both native LH-RH (100 micrograms) and intravenous pulsatile LH-RH did not evoke any rise in LH. In addition to the above LH-RH challenges, the positive feedback was examined by administration of estradiol benzoate (EB). The study demonstrated that, although the pituitary did not respond to any LH-RH challenge, it may still respond by a rise in LH following EB administration. Both functions of the hypothalamic pituitary axis should be examined in order to determine the state of medical hypophysectomy.
|
pubmed:language |
eng
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Buserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Luteolytic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Triptorelin Pamoate
|
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-11
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2972166-Administration, Intranasal,
pubmed-meshheading:2972166-Buserelin,
pubmed-meshheading:2972166-Drug Administration Schedule,
pubmed-meshheading:2972166-Female,
pubmed-meshheading:2972166-Follicle Stimulating Hormone,
pubmed-meshheading:2972166-Gonadotropin-Releasing Hormone,
pubmed-meshheading:2972166-Humans,
pubmed-meshheading:2972166-Hypophysectomy,
pubmed-meshheading:2972166-Hypophysectomy, Chemical,
pubmed-meshheading:2972166-Infertility, Female,
pubmed-meshheading:2972166-Injections, Subcutaneous,
pubmed-meshheading:2972166-Luteinizing Hormone,
pubmed-meshheading:2972166-Luteolytic Agents,
pubmed-meshheading:2972166-Polycystic Ovary Syndrome,
pubmed-meshheading:2972166-Triptorelin Pamoate
|
pubmed:articleTitle |
Abolishment of the positive feedback mechanism: a criterion for temporary medical hypophysectomy by LH-RH agonist.
|
pubmed:affiliation |
Department of Obstetrics, Gynecology and Endocrinology, Chaim Sheba Medical Center, Sackler Medical School, Tel-Aviv University, Tel-Hashomer, Israel.
|
pubmed:publicationType |
Journal Article
|